The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
International Journal of Chronic Obstructive Pulmonary Disease · 2023
DOI: 10.2147/copd.s434588 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2023. Verfasst von Weimin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People's Republic of China. Hauptthemen laut MEDLINE: Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Trial Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
- Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
- Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.
- Clinical & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA.
- Clinical & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Barcelona, Spain.
- Statistics, Phastar, Chiswick, London, UK.
ORCID-Profile: Weimin Li
Zitieren
APA
Li, W., Daoud, S. Z., Trivedi, R., Lukka, P. B., Jimenez, E., Molins, E., Stewart, C., Bharali, P., & Garcia-Gil, E. (2023). The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s434588
Vancouver
Li W, Daoud SZ, Trivedi R, Lukka PB, Jimenez E, Molins E, et al. The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants. International Journal of Chronic Obstructive Pulmonary Disease. 2023. doi:10.2147/copd.s434588
BibTeX
@article{Li2023,
author = {Li, Weimin and Daoud, Sami Z and Trivedi, Roopa and Lukka, Pradeep B and Jimenez, Eulalia and Molins, Eduard and Stewart, Catherine and Bharali, Pranob and Garcia-Gil, Esther},
title = {The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2023},
doi = {10.2147/copd.s434588}
}
EUVIMED